This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Dupuytren's Contracture
and you are
over 20
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

To investigate the efficacy and safety of AK160 in patients with Dupuytren's Contracture. To determine plasma concentration after the first injection of AK160 in patients with Dupuytren's Contracture.

Provided treatments

  • Drug: Collagenase Clostridium Histolyticum

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01588353. The sponsor of the trial is Asahi Kasei Pharma Corporation and it is looking for 104 volunteers for the current phase.
Official trial title:
Phase III Study of AK160 in Patients With Dupuytren's Contracture